AfricaRegulatory
African Pharmaceutical Regulatory Intelligence
NICARDIPINE
31 registrations across 5 African markets— 22 active
Markets with NICARDIPINE
Recent registrations
| Brand / Product | Market | Holder | Status | Expires |
|---|---|---|---|---|
| LOXEN 10MG/10 ML SOLUTION INJECTABLE POUR INJECTABLEION IV BOITE DE 5 | 🇨🇮Côte d'Ivoire | LABORATOIRE X.O | expired | Sept 2024 |
| NICARDIPINE AGUETTANT 1MG/ML SOLUTION INJECTABLE IV BOITE DE 10 | 🇨🇮Côte d'Ivoire | FRILAB SA | expired | Jun 2024 |
| LOXEN LP 50MG GELULE BOITE DE 60 | 🇨🇮Côte d'Ivoire | LABORATOIRE X.O | expired | May 2024 |
| LOXEN LP 20MG COMPRIME SECABLE BOITE DE 30 | 🇨🇮Côte d'Ivoire | LABORATOIRE X.O | expired | May 2024 |
| LOXEN LP Gélule à libération prolongée / 50 MG | 🇹🇳Tunisia | CARDIXO | expired | Jun 2022 |
| LOXEN LP Gélule à libération prolongée / 50 mg | 🇹🇳Tunisia | TERIAK | expired | Sept 2020 |
| NICARDIPINE MÉDIS Solution injectable / 10 mg/10 ml IV | 🇹🇳Tunisia | LES LABORATOIRES MEDIS | expired | Nov 2012 |
| LOXEN Comprimé sécable / 20 MG | 🇹🇳Tunisia | NOVARTIS Pharma S.A.S | expired | Oct 1990 |
| LOXEN Solution injectable / 10 MG | 🇹🇳Tunisia | NOVARTIS Pharma S.A.S | expired | Oct 1990 |
| ICANAL COMPRIME | 🇲🇦Morocco | — | active | — |
| LOXEN LP 50 COMPRIME / 50mg | 🇸🇳Senegal | NORVATIS PHARMA | active | — |
| LOXEN INJECTABLE / 10mg/10ml | 🇸🇳Senegal | NORVATIS PHARMA | active | — |
| LOXEN LP GELULE LP | 🇲🇦Morocco | — | active | — |
| ICANAL RETARD COMPRIME LP | 🇲🇦Morocco | — | active | — |
| LOXEN SOLUTION INJECTABLE | 🇲🇦Morocco | — | active | — |
| LOXEN comprime / 20mg | 🇸🇳Senegal | LABORATOIRE X.O | active | — |
| LOXEN solution injectable / 1Omg / 10ml | 🇸🇳Senegal | LABORATOIRE X.O | active | — |
| LOXEN * SOLUTION INJECTABLE | 🇲🇦Morocco | — | active | — |
| LOXEN LP gelule / 50mg | 🇸🇳Senegal | LABORATOIRE X.O | active | — |
| LOXEN INJECTABLE / 10mg/10ml | 🇸🇳Senegal | NORVATIS PHARMA | active | — |
| LOXEN® 10MG/10ML SI IV BTE (5) AMP(10ML) X.O - TP Solution injectable, 5 | 🇲🇬Madagascar | LABORATOIRE X.O. | active | — |
| LOXEN comprime / 20mg | 🇸🇳Senegal | LABORATOIRE X.O | active | — |
| LOXEN LP gelule / 50mg | 🇸🇳Senegal | LABORATOIRE X.O | active | — |
| LOXEN COMPRIME SECABLE | 🇲🇦Morocco | — | active | — |
| LOXEN LP 50 COMPRIME / 50mg | 🇸🇳Senegal | NORVATIS PHARMA | active | — |
| LOXEN solution injectable / 1Omg / 10ml | 🇸🇳Senegal | LABORATOIRE X.O | active | — |
| LOXEN® 10MG/10ML SI IV BTE (5) AMP(10ML) X.O - TP Solution injectable, 5 | 🇲🇬Madagascar | LABORATOIRE X.O. | active | — |
| M-NICARDIPINE 20 CP(3x10) M-GENERIC Ltd comprimé 20mg (3x10) | 🇲🇬Madagascar | M-GENERIC Ltd | active | — |
| ICANAL COMPRIME | 🇲🇦Morocco | — | active | — |
| M-NICARDIPINE 20 CP(3x10) M-GENERIC Ltd comprimé 20mg (3x10) | 🇲🇬Madagascar | M-GENERIC Ltd | active | — |
| ICANAL RETARD COMPRIME LP | 🇲🇦Morocco | — | active | — |
NICARDIPINE in Africa — Regulatory Overview
NICARDIPINE is registered across 5 African markets with 31 total product registrations on file. Data is sourced directly from official national drug regulatory authorities including Senegal, Morocco, Tunisia, Côte d'Ivoire and 1 more. AfricaRegulatory refreshes this data daily from official government sources.
Of the 31 registrations, 22 (71%) are currently active. Regulatory affairs teams use AfricaRegulatory to track registration expiry dates, identify market incumbents, and monitor approval status across African markets without manual monitoring of each national regulator.